Synthesis and antitumor activity of 2-(m-substituted-benzoyl)baccatin III analogs from taxinine

Tetrahedron

Volumn 59, Issue 9, 2003, Pages 1529-1538

  Horiguchi, Tohru ^b   Oritani, Takayuki ^a   Kiyota, Hiromasa ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Antitumor activity; m azidobenzoyl; Taxinine; Taxol

Indexed keywords

4ALPHA ACETOXY 2ALPHA 2 AZIDOBENZOYLOXY 5BETA,20 EPOXY 9ALPHA,10BETA ISOPROPYLIDENDIOXY 11 TAXEN 13 ONE; 4ALPHA ACETOXY 2ALPHA 2 CHLOROBENZOYLOXY 5BETA,20 EPOXY 9ALPHA,10BETA ISOPROPYLIDENDIOXY 11 TAXEN 13 ONE; ACETIC ACID DERIVATIVE; BACCATIN III; HYDROXYL GROUP; TAXININE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG ACETYLATION; DRUG CONFORMATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOSPECIFICITY;

TAXUS;

EID: 0037463482     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(03)00048-6     Document Type: Article

References (28)

1. Wani M.C., Taylor H.L., Wall M.E., Coggon P., McPhail A.T. J. Am. Chem. Soc. 93:1971;2325-2327.
2. (a) Suffness M. Georg G.I., Chen T.T., Ojima I., Vyas D.M. Taxane anticancer agents: Basic science and current status; Georg. 1995;1-17 American Chemical Society, Washington, DC.
3. b) Suffness M., Wall M.E. Suffness M. Taxol: Science and applications. 1995;3-25 CRC, Boca Raton, FL.
4. (c) Holmes F.A., Kudelka A.P., Kavanagh J.J., Huber M.H., Ajani J.A., Valero V. Georg G.I., Chen T.T., Ojima I., Vyas D.M. Taxane Anticancer Agents: Basic Science and Current Status. 1995;31-57 American Chemical Society, Washington, DC
5. (d) Golspiel B.R. Pharmacotherapy. 17:1997;110S-125S.
6. (e) Farina V. The Chemistry and Pharmacology of Taxol and its Derivatives, Pharmacochemistry Library. Vol. 22:1995;Elsevier, Amsterdam.
7. Paclitaxel is the generic name for taxol, a registered trademark of Bristol-Myers Squibb; because of its greater familiarity, the term 'taxol' is used throughout.
8. He L., Jagtap P.G., Kingston D.G.I., Scen H.J., Orr G.A., Horwitz S.B. Biochemistry. 39:2000;3972-3978.
9. Taxinine and other related reactivities: (a) Kurono M., Nakadaira Y., Onuma S., Sasaki K., Nakanishi K. Tetrahedron Lett. 1963;2153-2156 (b) Woods M.C., Chiang H.C., Nakadaira Y., Nakanishi K. J. Am. Chem. Soc. 90:1968;522-523 (c) Bathini Y., Micetich R.G., Daneshtalab M. Synth. Commun. 24:1994;1513-1517 (d) Wiegerinck P.H.G., Fluks L., Hammink J.B., Mulders S.J.E., de Groot F.M.H., van Rozendaal H.L.M., Scheeren H.W. J. Org. Chem. 61:1996;7092-7100 (e) Uyeo S., Ueda K., Yamamoto Y., Maki Y. Yakugaku Zasshi (Japanese Journal). 84:1964;762-772.
10. Taxinine and other related reactivities: (a) Kurono M., Nakadaira Y., Onuma S., Sasaki K., Nakanishi K. Tetrahedron Lett. 1963;2153-2156 (b) Woods M.C., Chiang H.C., Nakadaira Y., Nakanishi K. J. Am. Chem. Soc. 90:1968;522-523 (c) Bathini Y., Micetich R.G., Daneshtalab M. Synth. Commun. 24:1994;1513-1517 (d) Wiegerinck P.H.G., Fluks L., Hammink J.B., Mulders S.J.E., de Groot F.M.H., van Rozendaal H.L.M., Scheeren H.W. J. Org. Chem. 61:1996;7092-7100 (e) Uyeo S., Ueda K., Yamamoto Y., Maki Y. Yakugaku Zasshi (Japanese Journal). 84:1964;762-772.
11. Taxinine and other related reactivities: (a) Kurono M., Nakadaira Y., Onuma S., Sasaki K., Nakanishi K. Tetrahedron Lett. 1963;2153-2156 (b) Woods M.C., Chiang H.C., Nakadaira Y., Nakanishi K. J. Am. Chem. Soc. 90:1968;522-523 (c) Bathini Y., Micetich R.G., Daneshtalab M. Synth. Commun. 24:1994;1513-1517 (d) Wiegerinck P.H.G., Fluks L., Hammink J.B., Mulders S.J.E., de Groot F.M.H., van Rozendaal H.L.M., Scheeren H.W. J. Org. Chem. 61:1996;7092-7100 (e) Uyeo S., Ueda K., Yamamoto Y., Maki Y. Yakugaku Zasshi (Japanese Journal). 84:1964;762-772.
12. Taxinine and other related reactivities: (a) Kurono M., Nakadaira Y., Onuma S., Sasaki K., Nakanishi K. Tetrahedron Lett. 1963;2153-2156 (b) Woods M.C., Chiang H.C., Nakadaira Y., Nakanishi K. J. Am. Chem. Soc. 90:1968;522-523 (c) Bathini Y., Micetich R.G., Daneshtalab M. Synth. Commun. 24:1994;1513-1517 (d) Wiegerinck P.H.G., Fluks L., Hammink J.B., Mulders S.J.E., de Groot F.M.H., van Rozendaal H.L.M., Scheeren H.W. J. Org. Chem. 61:1996;7092-7100 (e) Uyeo S., Ueda K., Yamamoto Y., Maki Y. Yakugaku Zasshi (Japanese Journal). 84:1964;762-772.
13. Taxinine and other related reactivities: (a) Kurono M., Nakadaira Y., Onuma S., Sasaki K., Nakanishi K. Tetrahedron Lett. 1963;2153-2156 (b) Woods M.C., Chiang H.C., Nakadaira Y., Nakanishi K. J. Am. Chem. Soc. 90:1968;522-523 (c) Bathini Y., Micetich R.G., Daneshtalab M. Synth. Commun. 24:1994;1513-1517 (d) Wiegerinck P.H.G., Fluks L., Hammink J.B., Mulders S.J.E., de Groot F.M.H., van Rozendaal H.L.M., Scheeren H.W. J. Org. Chem. 61:1996;7092-7100 (e) Uyeo S., Ueda K., Yamamoto Y., Maki Y. Yakugaku Zasshi (Japanese Journal). 84:1964;762-772.
14. (a) Cheng S.-H., Huang S., Gao Q., Golik J., Farina V. J. Org. Chem. 59:1997;1475-1484.
15. (b) Chaundhary A.G., Chordia M.D., Kingston D.G.I. J. Org. Chem. 60:1995;3260-3262.
16. (c) Cheng Y.-Z., Zhi L.-Y. Tetrahedron Lett. 38:1997;4113-4136.
17. Ettouati L., Ahond A., Poupat C., Potier P. Tetrahedron. 47:1991;9823-9838.
18. The 5-membered ring was formed under mild basic condition, see: (a) Farina V., Huang S. Tetrahedron Lett. 33:1992;3979-3982 (b) Wahl A., Guéritte-Voegelein F., Guénard D., Le Goff M.-T., Potier P. Tetrahedron. 48:1992;6965-6975.
19. The 5-membered ring was formed under mild basic condition, see: (a) Farina V., Huang S. Tetrahedron Lett. 33:1992;3979-3982 (b) Wahl A., Guéritte-Voegelein F., Guénard D., Le Goff M.-T., Potier P. Tetrahedron. 48:1992;6965-6975.
20. Holton R.A., Kim H.-B., Somoza C., Liang F., Biediger R.J., Boatman P.D., Shindo M., Smith C.C., Kim S., Nadizadeh H., Suzuki Y., Tao C., Vu P., Tang S., Zhang P., Murthi K.K., Gentile L.N., Lin J.H. J. Am. Chem. Soc. 116:1994;1599-1600.
21. Chen S.H., Farina V., Wei J.M., Long B.H., Fairchild C., Mamber S., Kadow J.F., Vyas D.M., Doyle J.W. Bioorg. Med. Chem. Lett. 5:1995;1027.
22. Swindell C.S., Britcher S.F. J. Org. Chem. 51:1986;793-797.
23. (a) Yamori T., Matsunaga A., Sato S., Yamazaki K., Komi A., Ishizu K., Mita I., Edatsugi H., Matsuba Y., Takezawa K., Nakanishi O., Kohno H., Nakajima Y., Komatsu H., Andoh T., Tsuruo T. Cancer Res. 59:1999;4042-4049
24. (b) Boyd M.R. Status of the National Cancer Institute Preclinical Antitumor Drug Discovery Screen: Implications for Selection of New Agents for Clinical Trial. Devita V.T. Jr., Hellman S., Rosenberg S.A. Cancer: Principles and Practice of Oncology Update. Vol. 3:1989;1-12 Lippincott, Philadelphia
25. (c) Paull K.D., Shoemaker R.H., Hodes L., Monks A., Scudiero D.A., Rubinstein L., Plowman J., Boyd M.R. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J. Natl Cancer Inst. 81:1989;1088-1092
26. (d) Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrichi M., Campbell H., Mayo J., Boyd M. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl Cancer Inst. 83:1991;757-766.
27. (a) Floss H.G., Mocek U. Suffness M. Taxol: Science and applications. 1995;3-25 CRC, Boca Raton, FL.
28. (b) Croteau R., Hefner J., Hefner J., Hezari M., Lewis N.G. Curr. Top. Plant Physiol. 15:1995;94-104.